Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prevalence of lipodystrophy and risk factors for dyslipidemia in HIV-infected children in Brazil.
Braz J Infect Dis. 2014 Jul-Aug;18(4):394-9. doi: 10.1016/j.bjid.2013.12.007. Epub 2014 Apr 30.
Braz J Infect Dis. 2014.
PMID: 24794884
Free PMC article.
Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.
Machado ES, Hofer CB, Costa TT, Nogueira SA, Oliveira RH, Abreu TF, Evangelista LA, Farias IF, Mercadante RT, Garcia MF, Neves RC, Costa VM, Lambert JS.
Machado ES, et al.
Sex Transm Infect. 2009 Apr;85(2):82-7. doi: 10.1136/sti.2008.032300. Epub 2008 Nov 5.
Sex Transm Infect. 2009.
PMID: 18987014
Free PMC article.
Item in Clipboard
Bioavailability of once- and twice-daily regimens of didanosine in human immunodeficiency virus-infected children.
Abreu T, Plaisance K, Rexroad V, Nogueira S, Oliveira RH, Evangelista LA, Rangel R, Silva IS, Knupp C, Lambert JS.
Abreu T, et al.
Antimicrob Agents Chemother. 2000 May;44(5):1375-6. doi: 10.1128/AAC.44.5.1375-1376.2000.
Antimicrob Agents Chemother. 2000.
PMID: 10770783
Free PMC article.
Item in Clipboard
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
PENPACT-1 (PENTA 9/PACTG 390) Study Team; Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS.
PENPACT-1 (PENTA 9/PACTG 390) Study Team, et al.
Lancet Infect Dis. 2011 Apr;11(4):273-83. doi: 10.1016/S1473-3099(10)70313-3. Epub 2011 Jan 31.
Lancet Infect Dis. 2011.
PMID: 21288774
Free PMC article.
Clinical Trial.
Item in Clipboard
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team.
Yin DE, et al.
Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.
Pediatrics. 2014.
PMID: 25266426
Free PMC article.
Clinical Trial.
Item in Clipboard
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G; PENPACT-1 (PENTA 9PACTG 390) Study Team.
Harrison L, et al.
J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):42-53. doi: 10.1097/QAI.0000000000000671.
J Acquir Immune Defic Syndr. 2015.
PMID: 26322666
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite